Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.9600 (5.06%) ($14.5200 - $16.3200) on Fri. Sep. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.33% (three month average) | RSI | 70 | Latest Price | $14.9600(5.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.2% a day on average for past five trading days. | Weekly Trend | ATRA advances 3.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(44%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -2.165% in a week (0% probabilities). VIXM(-32%) VXX(-27%) UNG(-11%) UUP(-9%) TLT(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.165% (StdDev 4.33%) | Hourly BBV | 0 () | Intraday Trend | 1.5% | | | |
|
5 Day Moving Average | $14.08(6.25%) | 10 Day Moving Average | $13.65(9.6%) | 20 Day Moving Average | $13.26(12.82%) | To recent high | -3.5% | To recent low | 67.3% | Market Cap | $1.112b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |